Blegdamsvej 3, 2200 København N
CURRICULUM VITAE: Jørgen Kurtzhals, *31 March 1960
Address: Strandvejen 59, 1. Tv., 2100 København Ø
Professor MSO, Centre for Medical Parasitology, Department of Immunology and Microbiology (ISIM), Faculty of Health Sciences, University of Copenhagen (KU) – since May 2013
Consultant, Dept. of Clinical Microbiology 7602, Rigshospitalet (RH) – since Nov 2009
Director, School of Medical Sciences and Head of Medical Studies, KU – February 2016-January 2019
Consultant and shareholder in the travel clinic, ‘Udlandsvaccinationen’ – Since 2000
• MD, KU 1987.
• Diploma in tropical medicine and hygiene, KU 1993.
• PhD Faculty of Health Sciences, KU 1994.
• Specialist in clinical microbiology, Danish Board of Health 2003.
Additional clinical experience and scientific positions prior to present employment:
• Clinical Microbiology (RH, Statens Serum Institut and Hvidovre Hospital), totally 11 years
• Other clinical positions totally 3½ years
• PhD student, RH, post doc and research lecturer, KU, totally 8 years
• The PhD included a total of 6 months stay (including field work) at Kenya Medical Research Institute
• 4½ years of the post doc/research lecturer employment I was posted in Accra where I lived and worked as visiting scholar at University of Ghana and research officer at Korle-Bu Teaching Hospital
• Head of medical studies and chairman of staff student committee (studienævnet), Medical school, KU
• Head of parasitology, member of ‘sundhedsfagligt råd’, and clinic-appointed professor, Department of Clinical Microbiology, RH
• Leader of the Pathogenesis team in Centre for Medical Parasitology (CMP, cmp.ku.dk)
• President World Federation of Parasitologists (wfpnet.org)
• Acting vice-dean, Faculty of Health Sciences, KU – 3 months (March-May 2017)
• Implementing partner in phase 1 of the Building Stronger Universities initiative of DANIDA
• Development and administration of research laboratories in Ghana (1994-98 and 2013-present mavareca.cmp.ku.dk)
• Administration and co-adminstration of more than 20 grants, including IPR and patent negotiations
• Grant reviewing for Danish and international agencies
• Member of the committee for national (Danish) guidelines in travel medicine.
Teaching, supervision and research collaborations:
• Course leader in clinical microbiology for medical students 2009-2015.
• Supervision of 14 PhD projects and >40 master and bachelor projects (Danish and international)
• Responsible for expert education in parasitology for specialist registrars in clinical microbiology
• Advanced technology collaboration with Grundfos and Unisensor plus Danish Technical University on water safety device (parasite sensor)
• Collaboration on drug development with Vifor Pharma Int., Switzerland and Novo Nordisk AS, Denmark
• Research collaborations with University of Ghana, University of Amsterdam, University of Sydney, London School of Hygiene and Tropical Medicine, Institut Pasteur Paris, Kenya Medical Research Institute, Ebonyi State University Nigeria, University of Leipzig, Jimma University Hospital Ethiopia, and others.
Major research areas:
Malaria pathogenesis and experimental therapy
• Clinical malaria research
• Biomedical research connected with clinical and epidemiological studies
• Animal and in vitro models of cerebral malaria and malarial anaemia
Childhood infections in developing countries
• Neonatal infections
• Infections and their relationship with nutrition with special focus on iron deficiency
• Hospital-acquired infections
• Novel diagnostic techniques
• Parasitic diseases and pneumocystis in immunocompromised patients
132 scientific papers plus 11 letters, editorials etc. in journals with peer review since 1988.
Scopus author ID: 10238852300 – H-index: 35
Citation metrics i Google Scholar (10 June 2018): Total citations: 6248. H-index: 42. http://scholar.google.com/citations?user=7hDMBYcAAAAJ
Kurtzhals JAL. Immuno-epidemiology of visceral leishmaniasis. A model for the study of immune responses to Leishmania donovani infection in humans. PhD thesis; KU: 1993.
1. Burckhardt S, Funk F, Kurtzhals J & Sørensen LM. Iron carbohydrate complex compounds for the intravenous therapy of malaria. WO/2012/104204
2. Andersen JG, Enemark HL, Al-Sabi MNS & Kurtzhals J. Detection device and method. PCT/DK2012/050497.
1. Kurtzhals JAL, Hey AS, Jardim A, Kemp M, Schaefer K-U, Odera EO, Christensen CBV, Githure JI, Olafson RW, Theander TG & Kharazmi A. Dichotomy of the human T-cell response to Leishmania antigens. II. Absent or TH2-like response to gp63 and TH1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients. Clin Exp Immunol 1994; 96: 416-421.
2. Madsen HO, Garred P, Thiel S, Kurtzhals JAL, Lamm LU, Ryder LP & Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155: 3013-3020.
3. Kurtzhals JAL, Rodrigues O, Addae M, Commey JOO, Nkrumah FK & Hviid L. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol 1997; 97: 169-174.
4. Kurtzhals JAL, Adabayeri V, Goka BQ, Akanmori BD, Oliver-commey JO, Nkrumah FK, Behr C & Hviid L. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 1998; 351: 1768-1772.
5. Nielsen MA, Staalsoe T, Kurtzhals JAL, Goka BQ, Dodoo D, Theander TG, Akanmori BD & Hviid L. Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and non-severe malaria and is modified by acquired immunity. J Immunol 2002; 168: 3444-3450.
6. Ostrowski SR, Ullum H, Goka BQ, Høyer-Hansen G, Adjei GO, Pedersen BK, Akanmori BD & Kurtzhals JAL. Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome. J Infect Dis 2005; 191: 1331-1341.
7. Adjei GO, Kristensen K, Goka BQ, Høgberg LCG, Alifrangis M, Rodrigues OP & Kurtzhals JAL. Effect of concomitant artesunate administration and CYP2C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria. Antimicrobial Agents Chemother 2008; 52: 4400-4406.
8. Hempel C, Combes V, Hunt NH, Kurtzhals JAL, Grau GER. CNS hypoxia is more pronounced in murine cerebral than non-cerebral malaria and reversed by erythropoietin. Am J Pathol 2011; 179: 1939-1950.
9. Rostved AA, Sassi M, Kurtzhals JAL, Sørensen SS, Rasmussen A, Ross C, Gogineni E, Huber C, Kutty G, Kovacs JA & Helweg-Larsen J. Outbreak of Pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii. Transplantation 2013; 96:834-842
10.Efunshile A, Ngwu B, Kurtzhals JAL, Sahar S, König B & Stensvold CR. Molecular detection of the carriage rate of four intestinal protozoa with Real-Time PCR—possible overdiagnosis of Entamoeba histolytica in Nigeria. Am J Trop Med Hyg 2015; 93: 257-62
11.DellaValle B, Hempel C, Staalsø T, Johansen FF & Kurtzhals JAL. Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria. Malaria J 2016; 15: 427.
12.Hempel C, Pasini E & Kurtzhals JAL. Endothelial Glycocalyx: Shedding Light on Malaria Pathogenesis. Trends Mol Med 2016; 22: 453-457.
13.Mørcke AM & Kurtzhals JAL. Eksamenskarakterer på medicinstudiet – skal, skal ikke. Ugeskr Laeger 2017; 179: V69006. (Editorial).
14.Castberg FC, Maretty L, Staalsoe T, Hempel C, Clasen-Linde E, Hviid L, Kurtzhals JAL. Increased Plasmodium chabaudi malaria mortality in mice with nutritional iron deficiency can be reduced by short-term adjunctive iron supplementation. Malaria J 2017; Malar J 2018;17:34.
15.Stauning MT, Bediako-Bowan A, Andersen LP, Opintan JA, Labi A-K, Kurtzhals J & Bjerrum S. Traffic flow and microbial air contamination in operating rooms at a major teaching hospital in Ghana. J Hosp Inf; in press.